Pulmonary hypertension (PH) is a pathophysiological disorder that may involve multiple
clinical conditions and may be associated with a variety of cardiovascular and respiratory …

Abstract Purpose of Review The right ventricle (RV) has a complex geometry and physiology
which is distinct from the left. RV dysfunction and failure can be the aftermath of volume …

Background Cardiac MRI measurements have diagnostic and prognostic value in the
evaluation of cardiopulmonary disease. Artificial intelligence approaches to automate …

Erratum: 2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension:
Developed by the task force for the diagnosis and treatment of pulmonary hypertension of the …

Background Right atrial (RA) area predicts mortality in patients with pulmonary
hypertension, and is recommended by the European Society of Cardiology/European …

Background Current European Society of Cardiology and European Respiratory Society
guidelines recommend regular risk stratification with an aim of treating patients with …

Managing patients with pulmonary hypertension (PH) in association with chronic lung
disease and/or hypoxia (PH-CLD) remains one of the most challenging areas in pulmonary …

Background Cardiac magnetic resonance (CMR) is the gold standard technique to assess
biventricular volumes and function, and is increasingly being considered as an end-point in …

Background Measures that can detect large treatment effects are important for monitoring
therapeutic effectiveness. The 2022 European Society of Cardiology/European Respiratory …

Approved therapies for the treatment of patients with pulmonary arterial hypertension (PAH)
mediate pulmonary vascular vasodilatation by targeting distinct biological pathways …